Related Experiment Videos
[Paralytic ileus due to vinorelbine]
Gaspar Esquerdo Galiana1, Hugo Briceño García, Cristina Llorca Ferrándiz
1Unidad de Oncología, Hospital General de Elda, Alicante, España. gasparesquerdo@yahoo.es
Summary
Malignant intestinal obstruction is common in cancer patients. A lung cancer patient developed paralytic ileus after vinorelbine treatment, highlighting the need to rule out conservative options before aggressive intervention.
Area of Science:
- Oncology
- Gastroenterology
- Pharmacology
Background:
- Intestinal obstruction is a frequent complication in cancer patients, with 80% of cases having a malignant cause.
- Occlusion mechanisms include luminal obstruction, intestinal muscle paralysis, and carcinomatosis with mesenteric involvement.
- Aggressive treatment is often indicated, but conservative management should be considered when appropriate.
Observation:
- A clinical case of a lung cancer patient presenting with paralytic ileus after vinorelbine therapy is described.
- Vinorelbine, a vinca alkaloid, is known for toxicities like neutropenia and peripheral neuropathy.
- Rarely, vinorelbine can induce ileus through autonomic neuropathy.
Findings:
- The patient's paralytic ileus was attributed to vinorelbine-induced autonomic neuropathy.
- This case underscores a potential adverse drug reaction mimicking malignant intestinal obstruction.
- Conservative treatment might be beneficial in such drug-induced cases.
Implications:
- It is crucial to differentiate drug-induced ileus from malignant bowel obstruction in cancer patients.
- Conservative management should be explored before resorting to aggressive interventions for occlusive syndromes.
- Understanding drug toxicities is essential for optimizing cancer patient care and treatment strategies.